Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Active, not recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT04747613· Phase 3· Novartis Pharmaceuticals· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error